Lemaitre Vascular LMAT
NASDAQ LMAT
$82.40 +0.08 (+0.10%)
As of: Aug 21, 2026 · 11:53 AM EDT

Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026)

Lemaitre Vascular (LMAT) posted quarterly Total Non-Current Liabilities of $221.6 million for Q1 2026, up 6.76% year-over-year from $207.6 million in Q1 2025, and little changed quarter-over-quarter from $220.7 million in Q4 2025.

Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Total Non-Current Liabilities for 17 consecutive years, with $221.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 6.76% year-over-year to $221.6 million; the TTM figure through Mar 2026 stood at $221.6 million (up 6.76% YoY), while the FY2025 annual figure was $220.7 million, up 3.28% from the prior year.
  • Total Non-Current Liabilities was little changed at $221.6 million in Q1 2026 per LMAT's latest filing, from $220.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $221.6 million in Q1 2026 and bottomed at $33.9 million in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $103.1 million across 5 years, with a median of $44.9 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities tumbled 51.37% — and 2025, when it surged 417.24%.
  • Lemaitre Vascular's Total Non-Current Liabilities stood at $40.1 million in 2022, then gained by 16.21% to $46.6 million in 2023, then surged by 358.48% to $213.7 million in 2024, then climbed by 3.28% to $220.7 million in 2025, then advanced by 0.4% to $221.6 million in 2026.
  • Business Quant data shows LMAT's Total Non-Current Liabilities at $221.6 million in Q1 2026, $220.7 million in Q4 2025, and $218.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Intuitive Surgical 135.11 Bn 129.89 Bn 1.96 Bn 1.92 Bn
2 Becton Dickinson 52.51 Bn 51.65 Bn 2.32 Bn 48.34 Bn
3 Alcon 35.73 Bn 34.38 Bn 1.68 Bn 6.34 Bn
4 Resmed 33.94 Bn 32.47 Bn 861.22 Mn 985.45 Mn
5 Medline 29.02 Bn 26.34 Bn 2.22 Bn 17.56 Bn
6 West Pharmaceutical Services 24.95 Bn 24.51 Bn 329.20 Mn 996.30 Mn
7 Solventum 15.28 Bn 14.87 Bn 1.29 Bn 8.96 Bn
8 Cooper Companies 14.83 Bn 14.69 Bn 735.40 Mn 3.98 Bn
9 Baxter International 13.65 Bn 11.50 Bn 1.03 Bn 12.41 Bn
10 Lemaitre Vascular 1.88 Bn 1.51 Bn 50.76 Mn 218.75 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 218.75 Mn
Mar 31, 2026 221.59 Mn
Dec 31, 2025 220.71 Mn
Sep 30, 2025 218.21 Mn
Jun 30, 2025 213.97 Mn
Mar 31, 2025 207.56 Mn
Dec 31, 2024 213.70 Mn
Sep 30, 2024 45.69 Mn
Jun 30, 2024 41.37 Mn
Mar 31, 2024 44.86 Mn
Dec 31, 2023 46.61 Mn
Sep 30, 2023 43.23 Mn
Jun 30, 2023 42.06 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 40.11 Mn
Sep 30, 2022 38.40 Mn
Jun 30, 2022 40.70 Mn
Mar 31, 2022 33.90 Mn
Dec 31, 2021 38.51 Mn
Sep 30, 2021 40.29 Mn